Federal Register Notice: FDA’s Ophthalmic Devices Panel will meet 4/8, from 8:30 a.m. to 6 p.m. at the Hilton Washington, DC North/Gaithersburg, Salons A, B, C, and D, 620 Perry Pkwy., Gaithersburg, MD. The committee will discuss, make recommendations, and vote on a Bausch and Lomb PMA for the Trulign Toric posterior chamber intraocular lens intended for primary implantation in the capsular bag of the eye for visual correction of aphakia and postoperative refractive astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia, who desire improved uncorrected distance vision and reduction of residual refractive cylinder. Trulign Toric provides about one diopter of monocular accommodation, which allows for near, intermediate, and distance vision without spectacles. Contact Natasha Facey, (301) 796-5290. To view this notice, click here.